The biopharmaceutical company AstraZeneca announced it will $50 billion into the United States, with plans to open several ...

The U.K.-based drugmaker plans to invest $50 billion in the United States as the industry seeks to appease President Trump.

The investment will fund a new drug manufacturing facility in Virginia, and expand research and development in at least 5 ...

With the threat of tariffs looming for medicines imported to the United States, AstraZeneca has unveiled a plan to invest $50 ...

AstraZeneca has increased its investment in U.S. operations more than 14-fold, committing $50 billion to a range of ...

British-Swedish pharmaceutical company AstraZeneca announced a $50 billion investment in the U.S. this week, with the Trump ...

AstraZeneca says it’ll invest $50 billion in the United States by 2030 as President Donald Trump threatens steep tariffs on drug imports. The pharmaceutical giant Astra Zeneca has announced it's to ...

The $50 billion target, which AstraZeneca plans to meet by 2030, includes new manufacturing projects in Virginia and ...

The deal, which Youngkin signed on Monday, has not been reviewed by the Democrat-controlled General Assembly. The governor ...

British pharmaceutical giant AstraZeneca said Tuesday it would invest $50 billion in the United States by 2030 amid Donald ...

AstraZeneca plans to construct a multi-billion dollar manufacturing center focused on chronic diseases in Virginia within the next five years.

British pharmaceutical giant AstraZeneca said Tuesday it would invest $50 billion in the United States amid a looming ...